Velvic developed a marketing strategy for Immunovia's rights issue, where we selected relevant channels, created advertising materials, and developed a modern and user-friendly landing page for the offer.

A comprehensive data analysis was conducted, measuring the ROI for various channels, messages, and A/B tested ads. We also gained valuable insights into the interested investor target groups, the channels they used, and which information different segments were most interested in on the landing page.

See the landing page here!

Velvic developed a comprehensive marketing strategy and created customized communication materials for carefully selected channels, with the aim of communicating the offer of Moberg Pharma's warrants during the spring and summer of 2024.

An in-depth data analysis was conducted to provide insights into the investor target groups and to evaluate the effectiveness of the campaign's messages and channels. The result was a subscription rate of 98%.

Velvic developed a marketing strategy, created advertising materials, and conducted an in-depth data analysis of the campaigns to give Scandion Oncology a better understanding of their investor target group. See the landing page here!

We conducted an in-depth analysis of Calliditas' Investor Relations page, focusing on traffic and user behavior to identify opportunities for improvement. This analysis revealed areas where investors were not achieving their goals or finding the information they sought, along with data outliers and reactions to report releases. We delivered a clear understanding of the website’s performance and valuable insights into the investor target group.

We assisted WntResearch with the marketing strategy for their rights issue by creating a comprehensive marketing plan and a digital advertising strategy based on insights from our database of previous marketing strategies.

We also developed a user-friendly landing page that gathered all the necessary information about the issue in one place. The landing page enabled us to track the performance of all channels and measure how well visitors converted into subscribers for the offer.

See the landing page here.

In collaboration with Shark Communication, we created a website to represent Ortoma's rights issue. We gained many new insights into the ROI of marketing mailings, channels, and campaigns for the issue.

See the landing page here.

We created a new visual language and a new website for Cord Communications in under a month. Cord Communications is a partner-owned communications advisor with a focus on IR and financial PR.

It was a fast, smooth, and enjoyable project. See Cord Communications' website here.

Together with our partner, Shark Communication, we helped develop a refreshed visual identity for Alzinova in connection with their rights issue and created a landing page to present the offer. This led to increased engagement from visitors, and we are very pleased with the result.

Here is the landing page we created for the issue.

In collaboration with Shark Communication, we created a landing page to represent Stayble's rights issue. We gained valuable new insights into the ROI of marketing mailings, channels, and campaigns for the issue. The rights issue was subscribed to 90%.

See the landing page here.

In collaboration with Shark Communication, we created a website to represent Spotlight's rights issue. The issue was oversubscribed by 161%.

See the landing page here.

In collaboration with Shark Communication, we created a website to represent Audientes' rights issue, which was subscribed to 100%.

See the landing page here.

In collaboration with Shark Communication, we created a website to represent Safeture's rights issue. The issue was oversubscribed by 106%.

See the landing page here.

‍Lokon Pharma entrusted us with the task of creating a website that would clearly and engagingly present the company to the world. We designed and developed an entirely new website from the ground up, making their industry-specific research expertise easy to understand. At the same time, we explained their research process and made it easy for patients to sign up for ongoing studies. See the new website here.